• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Cancer Treatments May Be Linked to Decline in Cognitive Performance

UCLA researchers conducted a study of survivors of breast cancer to better understand if lower activity of telomerase (an enzyme that helps maintain the health of cells) along with DNA damage (a factor in cellular aging) were associated with worse cognitive performance, such as attention and motor skills. The study showed that lower telomerase activity and more DNA damage were associated with worse cognitive performance.

Cancer Treatments May Be Linked to Decline in Cognitive Performance

Mean population-normalized neuropsychological test score by domain in cancer survivors categorized by low DNA damage and high DNA damage. Graph: Courtesy of Dr. Judith Carroll

Cancer treatments may accelerate biological aging in cells. A previous UCLA study published in December 2017 linked lower telomerase activity and more DNA damage with exposure to chemotherapy and radiation. Researchers assessed 94 women after they completed three-to-six years of breast cancer treatment. The researchers found that those who had been exposed to chemotherapy and/or radiation showed elevated levels of DNA damage in their blood cells and lower telomerase activity, compared to women who had undergone surgery alone.

In this new study, the UCLA team examined the participants’ DNA damage and telomerase activity compared to their cognitive function. If the telomerase activity is low, the telomere gets shorter and the cell dies. More active telomerase suggests a healthier cell and longer cell life. The same 94 women cited in the first study, who were between the ages of 36 and 69 and treated for early-stage breast cancer within the previous three-to-six years, participated in the new study. Investigators took blood samples to determine DNA damage, telomerase activity and evidence of increased inflammation. Cognitive function was assessed using a neuropsychological test and self-reporting among participants.

Some people who have had cancer treatments experience cognitive decline. The study’s findings identify the correlation among telomerase activity, DNA damage and cognitive function. The study provides preliminary evidence that may help to inform future research and provide interventions to prevent cognitive decline in people with cancer who receive chemotherapy and/or radiation treatments.

“Taken together, this research provides preliminary evidence that the cancer treatments can leave a lasting imprint on some individuals,” says Judith Carroll, PhD, associate professor of psychiatry and biobehavioral sciences and a member of UCLA’s Jonsson Comprehensive Cancer Center. “Our hope is that future research will target these biological aging pathways to prevent the cognitive declines experienced by some cancer survivors.

“Cognitive Performance in Survivors of Breast Cancer and Markers of Biological Aging,” Cancer, November 26, 2018


Previous
Two-cells-in-one Combo Could Be Platform to Bolster Leukemia Treatment
Next
Beyond the Ivory Tower


YOU ARE VIEWING

Winter 2019

Winter 2019
Printable PDF
IN THIS ISSUE
  • Forever Linked
  • UCLA Team Helps Create Facility for Ugandan Women Who Suffer Childbirth Injuries
  • Aggressive Prostate and Lung Cancers Are Driven by Common Mechanisms
  • Behavioral Risk Factors for Depression Vary with Age
  • UCLA Scientists Use Stem Cells to Study Genetics of Germ Cell Tumors
  • Promising Drug Strategy Could Slow Neurodegeneration
  • Two-cells-in-one Combo Could Be Platform to Bolster Leukemia Treatment
  • Cancer Treatments May Be Linked to Decline in Cognitive Performance
  • Beyond the Ivory Tower
  • Parasite Sleuth: Elissa Hallem, PhD
  • Heartbreak. And Hope
  • The Littlest Wookiee
  • The Long Road to Effectively Treat CF
  • Eat, Drink and Be Wary
  • The Doctor & the Refugee
  • Awards & Honors
  • In Memoriam
  • The Big Weekend
  • In Memoriam
  • Innovation and Courage Honored at UCLA Visionary Ball
  • $10 Million Gift Advances Programs in Women’s Health
  • Celebrating the 10th Anniversary of Ronald Reagan UCLA Medical Center
  • UCLA Mattel Children’s Hospital Hosts 19th Annual Party on the Pier
  • UCLA Operation Mend Marches Forward
  • UCLA Health Sound Body Sound Mind Celebrates 20 Years of Supporting School Fitness Programs
  • UCLA-Weizmann Institute Collaboration Advances Depression Research
  • UCLA Urology Honors Two Physicians
  • Dr. Anthony C. Arnold Named Inaugural Chair in Neurodegenerative Diseases
  • Gifts
  • A Drop in the Bucket
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth